poly I-poly C12U
Phase 2Terminated 0 views this week 0 watching💤 Quiet
Interest: 17/100
17
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
HIV Seropositivity
Conditions
HIV Seropositivity, HIV Infection
Trial Timeline
May 1, 2001 → Sep 1, 2005
NCT ID
NCT00035581About poly I-poly C12U
poly I-poly C12U is a phase 2 stage product being developed by AIM ImmunoTech for HIV Seropositivity. The current trial status is terminated. This product is registered under clinical trial identifier NCT00035581. Target conditions include HIV Seropositivity, HIV Infection.
What happened to similar drugs?
1 of 1 similar drugs in HIV Seropositivity were approved
Approved (1) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
12
Activity
0
Company
5
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00035893 | Phase 2 | Completed |
| NCT00035581 | Phase 2 | Terminated |
Competing Products
2 competing products in HIV Seropositivity
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Raltegravir | Merck | Approved | 43 |
| poly I-poly C12U | AIM ImmunoTech | Phase 2 | 25 |